Promising Growth in the Global Biotechnology Sector
Estimates from Prophecy Market Insights indicate that the global biotechnology sector is set to experience substantial growth from 2024 to 2034. This expansion is largely driven by advancements in genetic engineering and personalized medicine. Furthermore, the increasing recognition of biotechnology's potential to tackle environmental sustainability and global health issues continues to fuel demand. This upward trend is expected to maintain momentum throughout the forecast period.
Key Markets Influencing Biotechnology Growth
Several vital markets are instrumental in shaping the future of the biotechnology industry:
Omics-Based Clinical Trials Market
The omics-based clinical trials market, estimated at USD 31.5 billion in 2024, is anticipated to grow at a compound annual growth rate (CAGR) of 8.9% over the next decade. The rising need for personalized treatment plans is driving the swift adoption of precision medicine, which significantly contributes to this market's growth.
MedTech CMO Market
Valued at USD 61.3 billion in 2024, the MedTech contract manufacturing organization (CMO) market is projected to grow at a CAGR of 5.0% from 2024 to 2034. The primary catalyst for this growth is the increasing demand for outsourcing medical device production, driven by the need for specialized expertise and cost-effectiveness.
Cell and Gene Therapy CDMO Market
The global market for cell and gene therapy contract development and manufacturing organizations (CDMO) was valued at USD 4.4 billion in 2024, with an impressive projected CAGR of 28.90% through 2034. This growth is fueled by a surge in the development of advanced therapies and heightened investments in research.
Biologics CDMO Market
Expected to be valued at USD 18 billion in 2024, the biologics CDMO market is likely to experience a CAGR of 11.80% during the period from 2024 to 2034. This growth is driven by an expanding pipeline of biologic medications, largely due to the increasing prevalence of chronic diseases and the ongoing demand for innovative treatment options.
CAR-T Cell Therapy Market
The CAR-T cell therapy market is projected to grow from USD 2.7 billion in 2024, with a modest CAGR of 1.80% expected over the next decade. This growth is primarily supported by advancements in immunotherapy and a rising number of CAR-T cell treatments receiving regulatory approvals.
U.S. Cell and Gene Therapy CDMO Market
In the United States, the cell and gene therapy CDMO market is anticipated to reach USD 2.37 billion in 2024, with continued growth projected at a CAGR of 28.90% through 2034. This strong growth is bolstered by a favorable regulatory environment and increasing government support for advancements in gene and cell therapies.
GLP-1 Analogues Market
The GLP-1 analogues market was valued at USD 45.3 billion in 2024 and is expected to grow at a remarkable CAGR of 33% over the next decade. The expansion of this market is largely attributed to the rising rates of diabetes and obesity, along with the proven effectiveness of GLP-1 analogs in managing these conditions.
Emerging Trends in Biotechnology
The biotechnology sector is continually evolving, with several emerging areas gaining significant attention and investment:
Brain Health Supplements Market
The global market for brain health supplements, valued at USD 9.94 billion in 2024, is projected to grow at a CAGR of 9.7% by 2034. As the population ages, there is an increasing demand for products that support cognitive function and help combat age-related decline.
Cancer Immunotherapy Market
Expected to reach USD 158.5 billion in 2024, the cancer immunotherapy market is anticipated to grow at a CAGR of 14.2%. This growth reflects the rising prevalence of various cancer types worldwide and the demand for immunotherapies as alternative treatment options.
Tumor-Infiltrating Lymphocyte (TIL) Therapy Market
The TIL therapy market, valued at USD 0.1 billion in 2024, is projected to expand significantly at a CAGR of 40% through 2034, driven by promising clinical results and increased funding for cancer immunotherapy research.
About Prophecy Market Insights
Prophecy Market Insights is a dedicated market research and analytics firm that provides strategic support to its clients. The company offers in-depth analysis, insights into market trends, and assistance in identifying value opportunities across various sectors, including healthcare, pharmaceuticals, and biotechnology.
Contact Us
Prophecy Market Insights
US: 964 E. Badillo Street
#2042 Covina, CA 91724
US toll-free: +1 860 531 2574
Rest of World: +91 7775049802
Frequently Asked Questions
What is the expected growth of the biotechnology industry?
The global biotechnology industry is projected to see significant growth between 2024 and 2034, fueled by innovations and increasing demand.
What are the key markets influencing biotechnology growth?
Key markets include omics-based clinical trials, MedTech CMOs, and cell and gene therapy, among others.
What factors are fueling the growth of the cell and gene therapy market?
Major drivers of growth in the cell and gene therapy market include advancements in research and increased investments.
How is the cancer immunotherapy market performing?
The cancer immunotherapy market is experiencing substantial growth due to the rising prevalence of cancer and the demand for alternative treatment options.
Who is Prophecy Market Insights?
Prophecy Market Insights is a specialized market research firm that provides insights, strategies, and solutions to support clients in their business endeavors.
